MoneyWorks4Me

Gland Pharma informs about analyst meet

20 Sep 2023 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meeting with the Company to be 25th September 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1761.50
Dr. Reddys Labs. 1233.00
Cipla 1306.80
Lupin 1943.30
Zydus Lifesciences 1132.70
View more..